Timothy F Murphy1, Charmaine Kirkham2, Megan M Jones3, Sanjay Sethi4, Yong Kong5, Melinda M Pettigrew6. 1. Division of Infectious Diseases Department of Microbiology and Immunology Clinical and Translational Research Center, University at Buffalo, State University of New York. 2. Division of Infectious Diseases Clinical and Translational Research Center, University at Buffalo, State University of New York. 3. Department of Microbiology and Immunology Clinical and Translational Research Center, University at Buffalo, State University of New York. 4. Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine Veterans Affairs Western New York Healthcare System, Buffalo, New York. 5. Department of Molecular Biophysics and Biochemistry, W.M. Keck Biotechnology Resource Laboratory. 6. Department of Epidemiology of Microbial Diseases, Yale School of Public Health, Yale University, New Haven, Connecticut.
Abstract
BACKGROUND: Immunoglobulin (Ig)A proteases of Haemophilus influenzae are highly specific endopeptidases that cleave the hinge region of human IgA1 and also mediate invasion and trafficking in human respiratory epithelial cells, facilitating persistence of H. influenzae. Little is known about the expression of IgA proteases in clinical settings of H. influenzae infection. METHODS: We identified and characterized IgA protease genes in H. influenzae and studied their expression and proteolytic specificity, in vitro and in vivo in 169 independent strains of H. influenzae collected longitudinally over 10 years from adults with chronic obstructive pulmonary disease. RESULTS: The H. influenzae pangenome has 2 alleles of IgA protease genes; all strains have igaA, and 40% of strains have igaB. Each allele has 2 variants with differing proteolytic specificities for human IgA1. A total of 88% of 169 strains express IgA protease activity. Expression of the 4 forms of IgA protease varies among strains. Based on the presence of IgA1 fragments in sputum samples, each of the different forms of IgA protease is selectively expressed in the human airways during infection. CONCLUSIONS: Four variants of IgA proteases are variably expressed by H. influenzae during infection of the human airways.
BACKGROUND: Immunoglobulin (Ig)A proteases of Haemophilus influenzae are highly specific endopeptidases that cleave the hinge region of humanIgA1 and also mediate invasion and trafficking in human respiratory epithelial cells, facilitating persistence of H. influenzae. Little is known about the expression of IgA proteases in clinical settings of H. influenzaeinfection. METHODS: We identified and characterized IgA protease genes in H. influenzae and studied their expression and proteolytic specificity, in vitro and in vivo in 169 independent strains of H. influenzae collected longitudinally over 10 years from adults with chronic obstructive pulmonary disease. RESULTS: The H. influenzae pangenome has 2 alleles of IgA protease genes; all strains have igaA, and 40% of strains have igaB. Each allele has 2 variants with differing proteolytic specificities for humanIgA1. A total of 88% of 169 strains express IgA protease activity. Expression of the 4 forms of IgA protease varies among strains. Based on the presence of IgA1 fragments in sputum samples, each of the different forms of IgA protease is selectively expressed in the human airways during infection. CONCLUSIONS: Four variants of IgA proteases are variably expressed by H. influenzae during infection of the human airways.
Authors: Emma Meats; Edward J Feil; Suzanna Stringer; Alison J Cody; Richard Goldstein; J Simon Kroll; Tanja Popovic; Brian G Spratt Journal: J Clin Microbiol Date: 2003-04 Impact factor: 5.948
Authors: Timothy F Murphy; Aimee L Brauer; Andrew T Schiffmacher; Sanjay Sethi Journal: Am J Respir Crit Care Med Date: 2004-04-29 Impact factor: 21.405
Authors: Livia Shehaj; Santosh K Choudary; Kamlesh M Makwana; Mary C Gallo; Timothy F Murphy; Joshua A Kritzer Journal: ACS Infect Dis Date: 2019-05-03 Impact factor: 5.084
Authors: Julia W Angkeow; Daniel R Monaco; Athena Chen; Thiagarajan Venkataraman; Sahana Jayaraman; Cristian Valencia; Brandon M Sie; Thomas Liechti; Payam N Farhadi; Gabriela Funez-dePagnier; Cheryl A Sherman-Baust; May Q Wong; Ingo Ruczinski; Patrizio Caturegli; Cynthia L Sears; Patricia J Simner; June L Round; Priya Duggal; Uri Laserson; Theodore S Steiner; Ranjan Sen; Thomas E Lloyd; Mario Roederer; Andrew L Mammen; Randy S Longman; Lisa G Rider; H Benjamin Larman Journal: Immunity Date: 2022-05-31 Impact factor: 43.474
Authors: Timothy F Murphy; Charmaine Kirkham; Mary C Gallo; Yang Yang; Gregory E Wilding; Melinda M Pettigrew Journal: J Infect Dis Date: 2017-12-05 Impact factor: 5.226
Authors: Karl J Staples; Stephen Taylor; Steve Thomas; Stephanie Leung; Karen Cox; Thierry G Pascal; Kristoffer Ostridge; Lindsay Welch; Andrew C Tuck; Stuart C Clarke; Andrew Gorringe; Tom M A Wilkinson Journal: PLoS One Date: 2016-11-29 Impact factor: 3.240